SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States. The company is headquartered in New York, New York. Show more

31 EAST 62ND STREET, NEW YORK, NY, UNITED STATES, 10065, New York, NY, 10065, USA

DRUG MANUFACTURERS - SPECIALTY & GENERIC

HEALTHCARE

Market Cap

218.8M

52 Wk Range

$2.86 - $8.36

Previous Close

$3.05

Open

$3.07

Volume

1,019,763

Day Range

$2.86 - $3.08

Enterprise Value

101.6M

Cash

117.6M

Avg Qtr Burn

N/A

Insider Ownership

42.73%

Institutional Own.

50.63%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TPOXX (Intravenous) Details Smallpox, Vaccine	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TPOXX® (tecovirimat) Details Smallpox	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.